Vitelliform macular dystrophy
Vitelliform macular dystrophy (VMD), also known as Best disease, is a rare, genetic eye disorder that affects the retina. It is characterized by the accumulation of yellowish material in the macula, the central part of the retina responsible for sharp, central vision.
Symptoms[edit | edit source]
The symptoms of Vitelliform macular dystrophy typically begin in childhood or adolescence, although they can appear later in life. The most common symptom is a gradual decline in central vision, which can affect one or both eyes. Other symptoms may include distorted vision (metamorphopsia), trouble distinguishing between colors (color blindness), and sensitivity to bright light (photophobia).
Causes[edit | edit source]
Vitelliform macular dystrophy is caused by mutations in the BEST1 gene. This gene provides instructions for making a protein that is found in the retina. The protein plays a crucial role in the normal functioning of the retina's light-sensing cells. Mutations in the BEST1 gene disrupt the normal functioning of these cells, leading to the symptoms of Vitelliform macular dystrophy.
Diagnosis[edit | edit source]
Diagnosis of Vitelliform macular dystrophy is typically made through a comprehensive eye examination, including a detailed examination of the retina. Additional tests may include electroretinography (ERG), optical coherence tomography (OCT), and genetic testing to identify mutations in the BEST1 gene.
Treatment[edit | edit source]
There is currently no cure for Vitelliform macular dystrophy. Treatment is focused on managing symptoms and slowing the progression of the disease. This may include the use of low-vision aids, such as magnifying glasses and large-print materials, and referral to services for individuals with visual impairment.
Prognosis[edit | edit source]
The prognosis for individuals with Vitelliform macular dystrophy varies. Some individuals may maintain good vision into adulthood, while others may experience a significant decline in vision. Regular follow-up with an ophthalmologist is important to monitor for changes in vision and to manage any complications that may arise.
See also[edit | edit source]
References[edit | edit source]
 | This genetics article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
